Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ cIAP1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA598418
Description
cIAP1 Polyclonal Antibody for IHC (P), ELISA
The protein encoded by this gene is a member of a family of proteins that inhibits apoptosis by binding to tumor necrosis factor receptor-associated factors TRAF1 and TRAF2, probably by interfering with activation of ICE-like proteases. This encoded protein inhibits apoptosis induced by serum deprivation and menadione, a potent inducer of free radicals.
Specifications
cIAP1 | |
Polyclonal | |
Unconjugated | |
BIRC2 | |
Api1; Api2; apoptosis inhibitor 1; apoptosis inhibitor 2; AW146227; baculoviral IAP repeat containing 2; baculoviral IAP repeat-containing 2; baculoviral IAP repeat-containing 3; baculoviral IAP repeat-containing protein 2; baculoviral IAP repeat-containing protein 2; putative inhibitor of apoptosis; BIRC2; Birc3; cellular inhibitor of apoptosis 1; cIAP1; C-IAP1; cIAP2; HIAP1; HIAP2; Hiap-2; IAP homolog B; IAP1; IAP2; IAP-2; inhibitor of apoptosis protein; inhibitor of apoptosis protein 2; LOC100622859; mcIAP1; MIAP1; MIAP2; mIAP-2; MIHB; MIHC; NFR2-TRAF signalling complex protein; rIAP1; RING finger protein 48; RING-type E3 ubiquitin transferase BIRC2; RNF48; TNFR2-TRAF-signaling complex protein 2 | |
Rabbit | |
Antigen Affinity Chromatography | |
RUO | |
329 | |
-20°C or -80°C if preferred | |
Liquid |
ELISA, Immunohistochemistry (Paraffin), Western Blot | |
0.52 mg/mL | |
PBS with 50% glycerol and 0.02% sodium azide; pH 7.3 | |
Q13490 | |
BIRC2 | |
Recombinant Human Baculoviral IAP repeat-containing protein 2 protein (1-300AA). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction